Research Facilities
Our Research Facilities offer cutting-edge expertise and high-quality components for pandemic sciences research. This includes producing high-quality vaccine vectors, providing technical expertise and equipment, and manufacturing vaccine candidates that can be tested in clinical trials.
Our Facilities provide a crucial link between academic research and clinical drug and vaccine development. As well as resourcing staff and students across the University of Oxford, we supply academic and industry partners around the world.
The Clinical Biomanufacturing Facility
Manufacturers of vaccines and advanced therapy medicinal products according to Good Manufacturing Principles for use in early clinical trials.
Viral Vector Core Facility
Producers of high-quality adenovirus and MVA vectors for laboratory and pre-clinical use.